Literature DB >> 11598623

Expression of fibroblast growth factor (FGF)-10 in human colorectal adenocarcinoma cells.

A Matsuike1, T Ishiwata, M Watanabe, G Asano.   

Abstract

Fibroblast growth factor (FGF) -10 (keratinocyte growth factor 2, KGF 2) is a new member of the FGF family that is mainly synthesized by mesenchymal cells and acts predominantly on epithelial cells in a paracrine manner. Its actions are dependent on its binding to the iiib isoform of the cell-surface FGF receptor 2 (FGFR2 iiib). FGF-10 is known to play an important role in fetal limb and lung development, skin wound healing and prostatic epithelial cell growth. In the present study, the expression of FGF-10 and FGFR2 iiib in five cultured human colorectal adenocarcinoma cell lines (COLO 205, DLD-1, HCT-15, SW 480 and WiDr) and the localization of FGF-10 messenger RNA (mRNA) and its protein in human colorectal cancer tissues from 10 patients were determined. All five colorectal cancer cell lines expressed FGF-10 mRNA and its protein. FGFR2 iiib mRNAs were expressed in these cells and the recombinant FGF-10 (1 ng/ml) increased the growth rate of COLO 205 cells. To determine the localization of FGF-10 protein and its mRNA in normal and cancerous human colorectal tissues, immunohistochemistry and in situ hybridization were performed. In normal colorectal tissues, FGF-10 and its mRNA were not detected. In contrast, moderate immunoreactivity was present in cancer cells in 5 of 10 colorectal cancer cases and mild immunoreactivity was recognized in adjacent fibroblasts. By using in situ hybridization, FGF-10 mRNA was observed in colorectal cancer cells and fibroblasts adjacent to cancer cells. These findings indicate that FGF-10 and its receptor, FGFR2 iiib expression in colorectal adenocarcinoma cells and FGF-10 may contribute to the growth of cells of this type.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11598623     DOI: 10.1272/jnms.68.397

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  7 in total

1.  Fibroblast growth factor 10 represses premature cell differentiation during establishment of the intestinal progenitor niche.

Authors:  Pia Nyeng; Maureen Ann Bjerke; Gitte Anker Norgaard; Xiaoling Qu; Sune Kobberup; Jan Jensen
Journal:  Dev Biol       Date:  2010-09-27       Impact factor: 3.582

2.  Fibroblast growth factor receptor 2: expression, roles, and potential as a novel molecular target for colorectal cancer.

Authors:  Yoko Matsuda; Junji Ueda; Toshiyuki Ishiwata
Journal:  Patholog Res Int       Date:  2012-06-04

3.  FGF8 promotes colorectal cancer growth and metastasis by activating YAP1.

Authors:  Rui Liu; Shan Huang; Yunlong Lei; Tao Zhang; Kui Wang; Bo Liu; Edouard C Nice; Rong Xiang; Ke Xie; Jingyi Li; Canhua Huang
Journal:  Oncotarget       Date:  2015-01-20

4.  Fibroblast growth factor-10 and epithelial-mesenchymal transition in colorectal cancer.

Authors:  Fatemeh Farajihaye Qazvini; Nasser Samadi; Mojtaba Saffari; Amir Nader Emami-Razavi; Reza Shirkoohi
Journal:  EXCLI J       Date:  2019-07-17       Impact factor: 4.068

5.  FGF8 induces epithelial-mesenchymal transition and promotes metastasis in oral squamous cell carcinoma.

Authors:  Yilong Hao; Yanxuan Xiao; Xiaoyu Liao; Shuya Tang; Xiaoyan Xie; Rui Liu; Qianming Chen
Journal:  Int J Oral Sci       Date:  2021-03-01       Impact factor: 6.344

6.  Negative regulation of fibroblast growth factor 10 (FGF-10) by polyoma enhancer activator 3 (PEA3).

Authors:  Athina-Myrto Chioni; Richard Grose
Journal:  Eur J Cell Biol       Date:  2009-05-02       Impact factor: 4.492

7.  In vitro and in vivo evaluation of the radiosensitizing effect of a selective FGFR inhibitor (JNJ-42756493) for rectal cancer.

Authors:  Maud Verstraete; Annelies Debucquoy; Annelies Gonnissen; Ruveyda Dok; Sofie Isebaert; Ellen Devos; William McBride; Karin Haustermans
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.